Eli Lilly Pays Utah $24 Million For Deceptive Marketing Of Zyprexa
False and misleading prescription drug advertising is very common and dangerous. Pharmaceutical companies deceptively encourage doctors, and to a lesser extent, the public, with marketing that misrepresents risks, promotes unproven uses, and makes unsubstantiated claims. And Eli Lilly was no stranger to the deliberate and deceptive marketing of “off label” prescriptions like Zyprexa, which is […]